Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 5 , Pages 326-331 , June 2010

The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients

Received 22 July 2008 ,Revised 25 February 2009 ,Accepted 1 April 2009.

References 

  1. WHO . Prevalence of diabetes worldwide. Geneva: WHO; 2007;
  2. CDC . Diabetes surveillance. Atlanta, GA: HHS; 2007;
  3. Duncan BB, Schmidt MI. The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther. 2006;8(1):7–17
  4. Galan P, de Bree A, Mennen L, Potier de Courcy G, Preziozi P, Bertrais S, et al. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries. J Nutr Health Aging. 2003;7:428–435
  5. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia. 2000;43:550–557
  6. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr. 2001;74:130–136
  7. Rosato R, Ciccone G, Bo S, Pagano GF, Merletti F, Gregori D. Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov chains and additive regression models. J Eval Clin Pract. 2007;13:422–428
  8. De Caterina R, Madonna R, Bertolotto A, Schmidt EB. n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care. 2007;30:1012–1026
  9. Mahan, L.K., Escott-Stump, S. Krause's food, Nutrition and diet therapy. 11th ed. Nutrition in cardiovascular disease. Philadelphia, PA; 2005, 592 p.
  10. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189:19–30
  11. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr. 2004;134:1806–1811
  12. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol. 2001;88:1139–1142
  13. Frenoux JM, Prost ED, Belleville JL, Prost JL. A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats. J Nutr. 2001;131:39–45
  14. Wander RC, Du SH. Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. Am J Clin Nutr. 2000;72:731–737
  15. Li D, Yu XM, Xie HB, Zhang YH, Wang Q, Zhou XQ, et al. Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids. 2007;76:293–297
  16. Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc. 2005;105(3):428–440
  17. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem. 1992;38:704–709
  18. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191
  19. Signorello MG, Segantin A, Passalacqua M, Leoncini G. Homocysteine decreases platelet NO level via protein kinase C activation. Nitric Oxide. 2009;20(2):104–113
  20. Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6–15
  21. Severus WE, Littman AB, Stoll AL. Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry. 2001;9(6):280–293
  22. Berstad P, Konstantinova SV, Refsum H, Nurk E, Vollset SE, Tell GS, et al. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am J Clin Nutr. 2007;85:1598–1605
  23. Piolot A, Blache D, Boulet L, Fortin LJ, Dubreuil D, Marcoux C, et al. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med. 2003;141:41–49
  24. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest. 2001;81:645–672
  25. Saedisomeolia A, Wood GL, Garg ML, Gibson GP, Wark ABP. Supplementation of long chain n-3 polyunsaturated fatty acids increases the utilization of lycopene in cultured airway epithelial cells. J Food Lipids. 2008;15:421–432
  26. Li D, Mann NJ, Sinclair AJ. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexenoic acid in healthy male subjects. Lipids. 2006;41(1):85–89
  27. Zeman M, Zak A, Vecka M, Tvrzicka E, Pisarikova A, Stankova B. Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination. Cas Lek Cesk. 2005;144:737–741
  28. Baro L, Fonolla J, Pena JL, Martinez-Ferez A, Lucena A, Jimenez J, et al. n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans. Clin Nutr. 2003;22:175–182
  29. Faschinger C, Schmut O, Wachswender C, Mossbock G. Glaucoma and oxidative stress. Determination of malondialdehyde – a product of lipid peroxidation. Ophthalmologe. 2006;103:953–959
  30. Iraz M, Erdogan H, Ozyurt B, Ozugurlu F, Ozgocmen S, Fadillioglu E. Brief communication: omega-3 essential fatty acid supplementation and erythrocyte oxidant/antioxidant status in rats. Ann Clin Lab Sci. 2005;35:169–173
  31. Vaagenes H, Muna ZA, Madsen L, Berge RK. Low doses of eicosapentaenoic acid, docosahexaenoic acid, and hypolipidemic eicosapentaenoic acid derivatives have no effect on lipid peroxidation in plasma. Lipids. 1998;33:1131–1137
  32. Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol. 1997;17:2576–2588
  33. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's Illustrated biochemistry. 27th ed.. McGraw-Hill; 2006;
  34. Billups KL, Kaiser DR, Kelly AS, Wetterling RA, Tsai MY, et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res. 2003;15:231–236

PII: S0939-4753(09)00097-0

doi: 10.1016/j.numecd.2009.04.002

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 5 , Pages 326-331 , June 2010

Article Tools